Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial of NGX-4010 (capsaicin 8% patch) for painful HIV-associated neuropathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Peripheral Nervous System Diseases

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: Pain, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-06-14